Related Experiment Videos
Analyzer transfer of a broad range high-sensitivity C-reactive protein immunoassay
1Department of Clinical Chemistry, Hĵpital Erasme, Université Libre de Bruxelles, Belgium. fcotton@ulb.ac.be
Clinical Laboratory
|August 14, 2001
Summary
This study adapted a C-reactive protein (CRP) assay for broader measurement ranges, simplifying clinical laboratory testing. The new method provides accurate CRP levels for both inflammation and cardiovascular risk assessment.
Area of Science:
- Clinical Chemistry
- Biomarker Analysis
- Laboratory Medicine
Background:
- C-reactive protein (CRP) is crucial for diagnosing inflammation and assessing cardiovascular risk.
- Current methods often require separate assays for different CRP concentration ranges (0.1-10 mg/L for cardiovascular risk, 5-300 mg/L for inflammation).
- This necessitates using multiple assay protocols or methods in clinical laboratories.
Purpose of the Study:
- To adapt the Roche C-Reactive Protein (Latex) kit for the Hitachi Modular P800 analyzer.
- To establish a single, broad-range assay for CRP measurement on the Hitachi Modular P800.
- To validate the adapted assay against existing high-sensitivity and traditional CRP assays.
Main Methods:
- Adaptation of the Roche C-Reactive Protein (Latex) kit for the Hitachi Modular P800 analyzer.
- Validation of the adapted assay against established high-sensitivity and traditional CRP assays.
- Performance evaluation including measuring range and imprecision analysis.
Main Results:
- Successful adaptation and validation of the CRP assay on the Hitachi Modular P800.
- The adapted assay demonstrated a broad measuring range of 0.10-171 mg/L.
- The method exhibited an imprecision of less than 5.5% and correlated well with other assays.
Conclusions:
- The adapted CRP assay offers a practical, broad-range solution for clinical laboratories.
- This single assay can be used for both inflammation and cardiovascular risk assessment.
- The method enhances efficiency and practicality in routine CRP measurements.